Known targets — ChEMBL curated mechanism
ACHEADRA2AADRA2BADRA2CBCHECHRNA4CHRNB2GHSRMAOBUGCG
The experimentally established mechanism targets of Tartaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB known ✓ | P27338 | 2/20 | 0.31 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.30 |
| ▸ | CXCR4 | P61073 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL29579904 | 1.00 | CXCR4 (1.00) | CXCR4KMT2AMEN1TAAR1LMNA | |
| Cadaverine Tartrate SCHEMBL15162047 | 0.93 | CXCR4 (0.87) | CXCR4KMT2AMEN1TAAR1LMNA | |
| SCHEMBL1637309 | 0.92 | CXCR4 (0.86) | CXCR4KMT2AMEN1TAAR1LMNA | |
| SCHEMBL1206161 | 0.91 | CXCR4 (1.00) | CXCR4KMT2AMEN1TAAR1LMNA | |
| SCHEMBL1637972 | 0.89 | CXCR4 (0.79) | CXCR4KMT2ATAAR1LMNANPC1 | |
| SCHEMBL1205955 | 0.88 | CXCR4 (0.92) | CXCR4KMT2AMEN1TAAR1LMNA | |
| SCHEMBL1638354 | 0.87 | CXCR4 (0.77) | CXCR4KMT2ATAAR1LMNANPC1 | |
| SCHEMBL1206755 | 0.86 | CXCR4 (0.75) | CXCR4KMT2AMEN1TAAR1LMNA | |
| SCHEMBL1636499 | 0.86 | CXCR4 (0.75) | CXCR4KMT2AMEN1TAAR1LMNA | |
| SCHEMBL1636474 | 0.86 | CXCR4 (0.75) | CXCR4KMT2AMEN1TAAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4544056-A1 | METHODS FOR TREATING A TUMOR IN A SUBJECT | TME Pharma AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| CN-119654415-A | Methods of treating tumors in a subject | TME制药股份公司 | 2025-03-18 | — | — | CN | disclosed |
| EP-3710577-B1 | HEMATOPOIETIC STEM CELLS WITH IMPROVED PROPERTIES | YEDA RES & DEV (IL) | 2024-05-29 | — | — | EP | disclosed |
| EP-4306640-A1 | METHOD FOR TREATING A TUMOR IN A SUBJECT | TME Pharma AG (DE) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023247651-A1 | METHODS FOR TREATING A TUMOR IN A SUBJECT | TME Pharma AG (DE) | 2023-12-28 | — | — | WO | disclosed |
| US-11834678-B2 | Hematopoietic stem cells with improved properties | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-12-05 | — | — | US | disclosed |
| US-11499194-B2 | CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2022-11-15 | — | — | US | disclosed |